Tamara L. Lotan

16.3k total citations · 2 hit papers
216 papers, 6.3k citations indexed

About

Tamara L. Lotan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tamara L. Lotan has authored 216 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Pulmonary and Respiratory Medicine, 65 papers in Oncology and 61 papers in Molecular Biology. Recurrent topics in Tamara L. Lotan's work include Prostate Cancer Treatment and Research (150 papers), Prostate Cancer Diagnosis and Treatment (71 papers) and Cancer, Lipids, and Metabolism (35 papers). Tamara L. Lotan is often cited by papers focused on Prostate Cancer Treatment and Research (150 papers), Prostate Cancer Diagnosis and Treatment (71 papers) and Cancer, Lipids, and Metabolism (35 papers). Tamara L. Lotan collaborates with scholars based in United States, Canada and Brazil. Tamara L. Lotan's co-authors include Angelo M. De Marzo, Jonathan I. Epstein, Jessica Hicks, Emmanuel S. Antonarakis, William B. Isaacs, Ashley E. Ross, George J. Netto, David M. Berman, Jeremy A. Squire and Howard I. Scher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Tamara L. Lotan

204 papers receiving 6.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical implications of PTEN loss in prostate cancer

2018 427 citations Ashley E. Ross, Angelo M. De Marzo et al. profile →
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

2014 375 citations Jonathan I. Epstein, Tamara L. Lotan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamara L. Lotan United States	46	4.4k	2.1k	1.8k	1.8k	610	216	6.3k
Elai Davicioni United States	46	4.4k 1.0×	2.7k 1.3×	1.4k 0.8×	2.5k 1.4×	962 1.6×	296	7.1k
Juan Miguel Mosquera United States	30	4.1k 0.9×	2.5k 1.2×	1.4k 0.8×	2.0k 1.1×	436 0.7×	122	5.7k
Yoon‐La Choi South Korea	51	4.0k 0.9×	2.8k 1.3×	3.9k 2.1×	2.0k 1.1×	1.0k 1.6×	288	8.3k
Marina Scarpelli Italy	38	3.3k 0.8×	2.4k 1.1×	1.3k 0.7×	1.4k 0.8×	1.8k 2.9×	302	6.2k
Rainer Kuefer Germany	37	3.8k 0.9×	3.7k 1.7×	1.2k 0.7×	2.0k 1.1×	585 1.0×	80	7.0k
Maria Cristina Manara Italy	45	2.4k 0.5×	2.9k 1.4×	1.6k 0.9×	1.3k 0.7×	357 0.6×	117	5.5k
Michael C. Haffner United States	34	2.5k 0.6×	2.8k 1.3×	1.2k 0.7×	1.5k 0.9×	314 0.5×	120	5.3k
Tarek A. Bismar Canada	37	2.6k 0.6×	2.4k 1.1×	1.1k 0.6×	1.3k 0.7×	302 0.5×	129	4.8k
Enrique de Álava Spain	40	3.8k 0.9×	2.7k 1.3×	1.9k 1.0×	953 0.5×	683 1.1×	186	6.9k
Brett S. Carver United States	38	3.8k 0.9×	4.6k 2.2×	1.1k 0.6×	2.9k 1.6×	1.7k 2.7×	141	8.6k

Countries citing papers authored by Tamara L. Lotan

Since Specialization

Citations

This map shows the geographic impact of Tamara L. Lotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara L. Lotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara L. Lotan more than expected).

Fields of papers citing papers by Tamara L. Lotan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara L. Lotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara L. Lotan. The network helps show where Tamara L. Lotan may publish in the future.

Co-authorship network of co-authors of Tamara L. Lotan

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara L. Lotan. A scholar is included among the top collaborators of Tamara L. Lotan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara L. Lotan. Tamara L. Lotan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Huili, Ana Teresa Amaral, Thiago Vidotto, et al.. (2025). mTOR ‐mediated upregulation of B7 ‐ H3 in MiT / TFE translocation renal cell carcinoma. The Journal of Pathology. 268(1). 77–88.

Antonarakis, Emmanuel S., Mohammed Alshalalfa, Benjamin A. Teply, et al.. (2025). Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 202–202. 2 indexed citations

Lis, Rosina T., Ying Huang, Emma H. Allott, et al.. (2025). Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer. Molecular Cancer Research. 23(12). 1025–1033.

Shanahan, Megan, Claire H. Pernar, Kathryn L. Penney, et al.. (2024). Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors. International Journal of Cancer. 156(10). 1898–1908. 2 indexed citations

Pruitt, Hawley C., Ya Guan, W. Nathaniel Brennen, et al.. (2023). Collagen VI deposition mediates stromal T cell trapping through inhibition of T cell motility in the prostate tumor microenvironment. Matrix Biology. 121. 90–104. 14 indexed citations

Iyer, Hari S., Kevin H. Kensler, Konrad H. Stopsack, et al.. (2023). Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1120–1123. 3 indexed citations

Omar, Mohamed, Zhuoran Xu, Daniela C. Salles, et al.. (2023). Abstract 5369: Detection of ERG:TMPRSS2 gene fusion in prostate cancer from histopathology slides using attention-based deep learning. Cancer Research. 83(7_Supplement). 5369–5369. 1 indexed citations

Marshall, Catherine H., Benjamin A. Teply, Su Jin Lim, et al.. (2023). Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.. Journal of Clinical Oncology. 41(16_suppl). 5087–5087. 4 indexed citations

Mendes, Adrianna A., Jiayun Lu, Harsimar Kaur, et al.. (2022). Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer. 128(12). 2269–2280. 18 indexed citations

10.

Faisal, Farzana A., Sanjana Murali, Harsimar Kaur, et al.. (2020). CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer. Clinical Cancer Research. 26(11). 2595–2602. 23 indexed citations

11.

Wu, Yishuo, Hongjie Yu, Shuwei Li, et al.. (2020). Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. European Urology Oncology. 3(2). 224–230. 38 indexed citations

12.

Heaphy, Christopher M., Michael C. Haffner, Mindy K. Graham, et al.. (2020). Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate. Human Pathology. 101. 70–79. 4 indexed citations

13.

Allott, Emma H., Ericka M. Ebot, Konrad H. Stopsack, et al.. (2019). Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clinical Cancer Research. 26(5). 1086–1093. 43 indexed citations

14.

Guedes, Liana B., Fawaz Almutairi, Michael C. Haffner, et al.. (2017). Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer. Clinical Cancer Research. 23(16). 4693–4703. 62 indexed citations

15.

Guedes, Liana B., Emmanuel S. Antonarakis, Michael T. Schweizer, et al.. (2017). MSH2 Loss in Primary Prostate Cancer. Clinical Cancer Research. 23(22). 6863–6874. 112 indexed citations

16.

Guedes, Liana B., Carlos L. Morais, Fawaz Almutairi, et al.. (2016). Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. Clinical Cancer Research. 22(18). 4651–4663. 25 indexed citations

17.

Sood, Anil K., Hameed A. Rahimi, Wenle Wang, et al.. (2013). Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma. Clinical Cancer Research. 20(4). 890–903. 261 indexed citations

18.

Ghosh, Susmita, et al.. (2013). mTOR Signaling Feedback Modulates Mammary Epithelial Differentiation and Restrains Invasion Downstream of PTEN Loss. Cancer Research. 73(16). 5218–5231. 11 indexed citations

19.

Lotan, Tamara L., Bora Gürel, Siobhan Sutcliffe, et al.. (2011). PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients. Clinical Cancer Research. 17(20). 6563–6573. 262 indexed citations

20.

Orvieto, Marcelo A., Tamara L. Lotan, Mark B. Lyon, et al.. (2007). Assessment of the LapraTy Clip for Facilitating Reconstructive Laparoscopic Surgery in a Porcine Model. Urology. 69(3). 582–585. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact